With improved survival, more bone sarcoma survivors are approaching middle age making it crucial to investigate the late effects of their cancer and its treatment. We investigated the long-term risks of adverse outcomes among 5-year bone sarcoma survivors within the British Childhood Cancer Survivor Study.

Authors: M.M. Fidler, C. Frobisher, J. Guha, K. Wong, J. Kelly, D.L. Winter, E. Sugden, R. Duncan, J. Whelan, R.C. Reulen, M.M. Hawkins and on behalf of the British Childhood Cancer Survivor Study (BCCSS) Steering Group.

Read full article